Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.27 USD | -2.43% | -3.63% | -9.11% |
May. 30 | Day One Biopharmaceuticals Sells Priority Review Voucher for $108 Million | MT |
May. 20 | BrightSpring Health Services Says Onco360 Selected as Pharmacy Partner for Ojemda | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.11% | 1.16B | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.35% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- DAWN Stock
- News Day One Biopharmaceuticals, Inc.
- Capital One Starts Day One Biopharmaceuticals at Overweight With $40 Price Target